Global API micronization market set to surge 49% by 2030, led by specialized industry pioneers

Data Compilation
#PharmaFlow

Pipeline Prospector August 2025: Novo’s Wegovy approved for MASH, Tonix Pharma’s fibromyalgia drug okayed

Stock Recap
#PipelineProspector

Olopatadine hydrochloride, Opatanol, Pataday, Patanase, Allelock

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

53 API Suppliers, 17 USDMF, 9 JDMF, 7 EU WC, 14 KDMF, 15 NDC API, 26 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

40 Drugs in Development

40 Drugs in Development

INTERMEDIATES

15 Intermediate Suppliers

15 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

89 FDF Dossiers, 37 FDA Orange Book, 13 Europe, 12 Canada, 5 South Africa, 22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION/DROPS;OPHTHALMIC - EQ 0.7% BASE, SOLUTION/DROPS;OPHTHALMIC - EQ 0.1% BASE, SOLUTION/DROPS;OPHTHALMIC - EQ 0.2% BASE, SPRAY, METERED;NASAL - 0.665MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 13 SPI Pharma, 3 DKSH, 4 Boai NKY Pharmaceuticals Ltd, 1 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Kirsch Pharma, 1 ACG Worldwide, 5 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 10 BASF, 1 Clariant, 10 Corel Pharma Chem, 1 Finar, 6 Gangwal Chemicals, 3 Ideal Cures, 1 Ingredion Pharma Solutions, 10 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 4 Microlex e.U, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 3 Roquette, 6 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material

EXCIPIENTS BY APPLICATIONS

36 Coating Systems & Additives, 31 Fillers, Diluents & Binders, 14 Controlled & Modified Release, 14 Parenteral, 14 Direct Compression, 13 Chewable & Orodispersible Aids, 12 Taste Masking, 11 Solubilizers, 10 Granulation, 9 Disintegrants & Superdisintegrants, 7 Thickeners and Stabilizers, 6 Film Formers & Plasticizers, 5 Co-Processed Excipients, 5 Empty Capsules, 4 Rheology Modifiers, 4 Vegetarian Capsules, 4 API Stability Enhancers, 3 Topical, 2 Coloring Agents, 1 Emulsifying Agents, 1 Lubricants & Glidants, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

51 News #PharmaBuzz

51 News #PharmaBuzz

GLOBAL SALES INFORMATION

10 US Medicaid Prescriptions, 12 Regulatory FDF Prices, 19 Annual Reports

MARKET PLACE

19 APIs, 5 FDF Dossiers

PATENTS & EXCLUSIVITIES

18 US Patents, 1 US Exclusivities, 6 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 Others

5 Others

ANALYTICAL

3 Analytical Methods

3 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Name of the Firm	Written Confirmation No.	Product Name	Issue Date	Valid Till	Address of the Firm
06/09/2025	FDC	India	M/s FDC Limited	WC-0055	Olopatadine Hydrochloride IH/USP/IP	08-08-2025	07-07-2028	Plot No. 19 & 20/2, MIDC, Dhatav, Taluka: Roha, District-Raigad, Maharashtra, India
06/09/2025	Indoco Remedies Limited	India	M/s. Indoco Remedies Ltd. (Limited Company)	WC-0152	Olopatadine Hydrochloride USP	05-08-2025	15-07-2028	Kilo Lab, R-92-93,15 Floor, T.T.C. M.I.D.C., Thane Belapur Road, Navi Mumbai., Rabale - 400701, Taluka: Rabale, District: Thane-Zone1, Maharashtra, India

Olopatadine Hydrochloride, Opatanol, Pataday, Patanase, Allelock

Olopatadine hydrochloride, Opatanol, Pataday, Patanase, Allelock

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

53 API Suppliers

17 USDMF

9 JDMF

7 EU WC

14 KDMF

15 NDC API

26 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

40 Drugs in Development

INTERMEDIATES

15 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

89 FDF Dossiers

37 FDA Orange Book

13 Europe

12 Canada

5 South Africa

22 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION/DROPS;OPHTHALMIC - EQ 0.7% BASE

SOLUTION/DROPS;OPHTHALMIC - EQ 0.1% BASE

SOLUTION/DROPS;OPHTHALMIC - EQ 0.2% BASE

SPRAY, METERED;NASAL - 0.665MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

13 SPI Pharma

3 DKSH

4 Boai NKY Pharmaceuticals Ltd

1 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

1 Pfanstiehl

3 Kirsch Pharma

1 ACG Worldwide

5 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

10 BASF

1 Clariant

10 Corel Pharma Chem

1 Finar

6 Gangwal Chemicals

3 Ideal Cures

1 Ingredion Pharma Solutions

10 Kerry

3 Kima Chemical

6 Lonza Capsugel

4 Microlex e.U

2 Novo Excipients

1 Pharmatrans-Sanaq

2 Pluviaendo

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

3 Roquette

6 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

2 The Dow Chemical Company

1 Ulanqab Kema New Material

EXCIPIENTS BY APPLICATIONS

36 Coating Systems & Additives

31 Fillers, Diluents & Binders

14 Controlled & Modified Release

14 Parenteral

14 Direct Compression

13 Chewable & Orodispersible Aids

12 Taste Masking

11 Solubilizers

10 Granulation

9 Disintegrants & Superdisintegrants

7 Thickeners and Stabilizers

SPRAY, METERED;NASAL - 0.665MG/SPRAY Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons